Michael Yee analyst JEFFERIES

Currently out of the existing stock ratings of Michael Yee, 247 are a BUY (80.72%), 59 are a HOLD (19.28%).

Michael Yee

Work Performance Price Targets & Ratings Chart

Analyst Michael Yee, currently employed at JEFFERIES, carries an average stock price target met ratio of 55.26% that have a potential upside of 35.19% achieved within 188 days.

Michael Yee’s has documented 612 price targets and ratings displayed on 37 stocks. The coverage is on Healthcare, Industrials, Pharmaceuticals sectors.

Most recent stock forecast was given on ALXO, Alx Oncology HoldingsĀ  at 06-Mar-2025.

Wall Street Analyst Michael Yee

Analyst best performing recommendations are on ALGS (ALIGOS THERAPEUTICSĀ ).
The best stock recommendation documented was for KOD (KODIAK SCIENCES) at 7/24/2023. The price target of $3 was fulfilled within 3 days with a profit of $0.95 (24.05%) receiving and performance score of 80.17.

Average potential price target upside

ACOR Acorda Therapeutics ADGI Adagio Therapeutics ALGS Aligos TherapeuticsĀ  AMRN Amarin PLC ASMB Assembly Biosciences EPZM Epizyme ESPR Esperion Therapeutics GILD Gilead Sciences ICPT Intercept Pharmaceuticals MRNA Moderna PRTA Prothena plc SDGR Schrodinger AMGN Amgen VRTX Vertex Pharmaceuticals AXON Axon Enterprise BIIB Biogen BMRN Biomarin Pharmaceutical CELG Celgene CERE Cerevel Therapeutics Holdings FGEN FibroGen ONCE Spark Therapeutics ODT Odonate Therapeutics ZLAB Zai Lab Ltd SRRK Scholar Rock Holding Corp VTYX Ventyx Biosciences NUVB Nuvation Bio IMCR Immunocore Holdings Ltd LIAN LianBio ADR ALLO Allogene Therapeutics KOD Kodiak Sciences ALXO Alx Oncology HoldingsĀ  BEAM Beam TherapeuticsĀ  RXDX Prometheus Biosciences DNLI Denali Therapeutics IMRX Immuneering Corp MORF Morphic OLMA Olema Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$200

$198.8 (16566.67%)

$3960

3 years 10 months 11 days ago
(17-Jun-2021)

0/4 (0%)

$103 (106.19%)

Buy

$100

$98.8 (8233.33%)

$3600

4 years 3 months 15 days ago
(13-Jan-2021)

2/4 (50%)

$-22.4 (-18.30%)

139

Hold

$120

$118.8 (9900.00%)

$2280

4 years 11 months 22 days ago
(06-May-2020)

5/5 (100%)

$16.79 (16.27%)

44

Hold

$120

$118.8 (9900.00%)

$3000

4 years 11 months 22 days ago
(06-May-2020)

6/6 (100%)

$16.79 (16.27%)

45

Sell

$120

$118.8 (9900.00%)

$1200

5 years 6 months 7 days ago
(21-Oct-2019)

7/7 (100%)

$-165.6 (-57.98%)

161

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Michael Yee is most bullish on?

Potential upside of $69.16 has been obtained for AMGN (AMGEN)

Which stock is Michael Yee is most reserved on?

Potential downside of $1.94 has been obtained for ALXO (ALX ONCOLOGY HOLDINGSĀ )

What Year was the first public recommendation made by Michael Yee?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?